Glipizide And Metformin Hcl Tablet, Film Coated
Product Images NDC 23155-117

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Glipizide And Metformin Hcl (NDC 23155-117). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 01

Chemical structure of Glipizide and Metformin HCl showing detailed molecular bonds and functional groups associated with the compound.*

FDA Label Image

Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 02

Chemical structure of Metformin Hydrochloride (HCl), a component of the Glipizide and Metformin HCl combination drug. The structure shows the arrangement of carbon, nitrogen, hydrogen atoms, and the attached hydrochloride.*

FDA Label Image

Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 03

A data table summarizing pharmacokinetic parameters of Metformin dose groups including healthy nondiabetic adults, adults with type 2 diabetes, elderly healthy nondiabetic adults, and renal-impaired adults at 850 mg single dose. Variables include peak plasma concentration (Cmax in µg/mL), time to peak plasma concentration (Tmax in hours), and renal clearance (mL/min) with subject group sizes and dose details.*

FDA Label Image

Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 04

This data table compares mean final doses, Hemoglobin A1c percentages, and fasting plasma glucose levels among Glipizide 5 mg tablets, Metformin 500 mg tablets, and their combinations in doses 2.5 mg/250 mg and 2.5 mg/500 mg. It shows baseline and final means, adjusted mean changes from baseline, and statistical differences for these parameters in clinical samples.*

FDA Label Image

Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 05

A data table comparing mean final doses, hemoglobin A1c percentages, and fasting plasma glucose values among Glipizide 5 mg tablets, Metformin 500 mg tablets, and combination Glipizide and Metformin HCl 5 mg/500 mg tablets, including baseline means, adjusted means, differences between groups, and percentage of patients with final HbA1c below 7%.*

FDA Label Image

Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 06

A data table presenting the number and percentage of patients experiencing various adverse events for different treatments: Glipizide 5 mg tablets, Metformin 500 mg tablets, and combinations of Glipizide and Metformin HCl tablets in strengths 2.5 mg/250 mg and 2.5 mg/500 mg. Adverse events listed include upper respiratory infection, diarrhea, dizziness, hypertension, and nausea/vomiting.*

FDA Label Image

Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 07

This data table presents the number and percentage of patients experiencing various adverse events during treatment with Glipizide 5 mg tablets, Metformin 500 mg tablets, and Glipizide and Metformin HCl 5 mg/500 mg tablets. Adverse events listed include diarrhea, headache, upper respiratory infection, musculoskeletal pain, nausea/vomiting, abdominal pain, and urinary tract infection (UTI).*

FDA Label Image

Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 08

A data table showing National Drug Codes (NDC) for Glipizide and Metformin HCl tablets in various strengths. It lists three combinations: 2.5 mg Glipizide with 250 mg Metformin hydrochloride, 2.5 mg Glipizide with 500 mg Metformin hydrochloride, and 5 mg Glipizide with 500 mg Metformin hydrochloride, with corresponding NDCs for bottles of 100 and 1000 tablets respectively.*

FDA Label Image

Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 09

FDA Label Image

Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 10

FDA Label Image

Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 11

Label for Glipizide and Metformin Hydrochloride Tablets USP containing 2.5 mg Glipizide and 250 mg Metformin HCl per tablet. The film-coated tablet packaging indicates 100 tablets per bottle. Labeler is Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. The label shows storage instructions, dosage reference to package insert, and a barcode.*

FDA Label Image

Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 12

Label for Glipizide and Metformin Hydrochloride Tablets USP 2.5 mg/500 mg film-coated tablets by Avet Pharma. The package contains 100 tablets with Rx only designation. Storage instructions specify to keep between 20-25°C (68-77°F) with US FDA controlled room temperature. Additional manufacturer and distributor information is included.*

FDA Label Image

Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 13

Glipizide and Metformin Hydrochloride Tablets USP 5 mg/500 mg film-coated tablet label from Avet Pharma, Heritage Pharmaceuticals Inc. The label indicates 100 tablets per package, prescription only, with storage instructions and manufacturer information in Daman, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.